People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BioIntervene, Inc. | — | Pharmaceuticals | Series A | $8.8M | $115.0M | 2021 |
David J. Bredt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David J. Bredt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ed Hurwitz | 1 | 9 |
| Simon J. Tate | 1 | 1 |
| Gary J. Bennett | 1 | 1 |
| Daniela J. Salvemini | 1 | 1 |
| Gary J. Patou | 1 | 1 |
| Ed J. Hurwitz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.